Erythropoietin and preoperative autologous blood donation in the prevention of hepatitis C infection:necessity or luxury?

Abstract

Despite the limitations of our model, the cost-effectiveness ratio was so large that variations only slightly modified the size of the result. From the societal perspective, it was not cost-effective to add rHuEPO to preoperative blood donation.